Tag: Insulin
In T2D, Glycemic Control Up With Continuous Glucose Monitoring
Improved glycemic control with CGM for patients with T2DM receiving multiple insulin injections daily
Insulin Degludec Linked to Reduced Rate of Hypoglycemia
Reduced rate of hypoglycemic episodes among patients with type 1 diabetes, type 2 diabetes
Genetic, Environmental Exposure Tied to Islet Autoantibodies
Link for male sex; father, sibling as diabetic proband; weight at 12 months with insulin autoantibodies
T1DM Patients With Active β-Cell Function Differ Immunologically
Findings for patients with remaining endogenous β-cell function after 10 or more years of T1DM
ADA: Degludec Noninferior for Cardiovascular Events in T2DM
Noninferior to glargine for incidence of major cardiovascular events in high-risk patients with T2DM
ADA: Glucose Self-Monitoring Often Lacks Benefit in T2DM
No significant improvements in hemoglobin A1c levels, HRQOL seen in non-insulin-treated cases
Breaking Up Sedentary Time With Upper Body Activity Beneficial
Short bouts of arm ergometry linked to reductions in mean blood glucose, insulin iAUC in obese individuals
Normal Meal Tolerance Test Is Practical, Reliable in T2DM
But glucagon stimulation test should be used instead for patients in hyperglycemic state
Fast-Acting Insulin Aspart Ups Glycemic Control in T1DM
Noninferior to conventional insulin aspart, with superior postprandial plasma glucose control
Insulin Resistance Predicts Later Cognitive Decline
Higher serum fasting insulin predicts future decline in verbal fluency
